Basics XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. IPO Date: July 1, 1986 Sector: Healthcare Industry: Biotech Market Cap: $425.97M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.12% Avg Daily Range (30 D): $0.69 | 2.32% Avg Daily Range (90 D): $0.58 | 2.12% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 392 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 38 Institutional Trades Total Inst.Trades: 381 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $2.61M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $3.52M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 78.23K     News Aug 4, 2025 @ 11:30 AM XOMA Royalty Enters into Agreement to Acquire LAVA... Source: Globe Newswire Aug 4, 2025 @ 11:00 AM HilleVax Enters into a Definitive Agreement to be ... Source: Not Specified Jun 30, 2025 @ 10:14 PM $HAREHOLDER ALERT: Class Action Attorney Juan Mont... Source: Juan Monteverde Jun 18, 2025 @ 11:30 AM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire May 27, 2025 @ 12:01 PM XOMA Royalty Purchases Mezagitamab Royalty and Mil... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.1 $.06 $-.45 Diluted EPS $-1.14 $.06 $-.45 Revenue $ 42.91M $ 15.91M $ 8.71M Gross Profit $ $ $ Net Income / Loss $ -2.86M $ 2.37M $ -3.97M Operating Income / Loss $ -27.04M $ 5.93M $ -7.25M Cost of Revenue $ $ $ Net Cash Flow $ -47.37M $ -11.39M $ -40.4M PE Ratio     Splits Oct 18, 2016:   1:20 Aug 18, 2010:   1:15